标题
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009
作者
关键词
-
出版物
CANCER
Volume 122, Issue 14, Pages 2206-2215
出版商
Wiley
发表日期
2016-04-19
DOI
10.1002/cncr.30023
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Glioblastoma in England: 2007–2011
- (2015) Andrew Brodbelt et al. EUROPEAN JOURNAL OF CANCER
- Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000–2010
- (2015) I-Wen Pan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Brain tumors in Sweden: Data from a population-based registry 1999–2012
- (2014) Thomas Asklund et al. ACTA ONCOLOGICA
- Population-based survival analyses of central nervous system tumors from 1994 to 2008. An up-dated study in the temozolomide-era
- (2014) Rafael Fuentes-Raspall et al. Cancer Epidemiology
- EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
- (2014) Michael Weller et al. LANCET ONCOLOGY
- Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- (2013) Terri S. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme
- (2012) Pål A. Rønning et al. NEURO-ONCOLOGY
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
- (2009) S. Nobusawa et al. CLINICAL CANCER RESEARCH
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Age as a Predictive Factor in Glioblastomas: Population-Based Study
- (2009) Daisuke Kita et al. NEUROEPIDEMIOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Promoter Methylation and Polymorphisms of the MGMT Gene in Glioblastomas: A Population-Based Study
- (2008) Izabela Zawlik et al. NEUROEPIDEMIOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started